The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a review

AY Chang, MR Cullen, RA Harrington… - Journal of internal …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is an ongoing global pandemic affecting all
levels of health systems. This includes the care of patients with noncommunicable diseases …

[HTML][HTML] Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain

AJ McFarland, MS Yousuf, S Shiers, TJ Price - Pain reports, 2021 - journals.lww.com
SARS-CoV-2 is a novel coronavirus that infects cells through the angiotensin-converting
enzyme 2 receptor, aided by proteases that prime the spike protein of the virus to enhance …

The clinical characteristics and risk factors of severe COVID-19

J Hu, Y Wang - Gerontology, 2021 - karger.com
Objective: We aim to investigate the clinical characteristics and risk factors for the severe
cases of coronavirus disease 2019 (COVID-19) in comparison with the non-severe patients …

Proliferation of papers and preprints during the coronavirus disease 2019 pandemic: progress or problems with peer review?

C Vlasschaert, JM Topf, S Hiremath - Advances in chronic kidney disease, 2020 - Elsevier
The coronavirus disease 2019 (COVID-19) pandemic has spread exponentially throughout
the world in a short period, aided by our hyperconnected world including global trade and …

The swedish covid‐19 intensive care cohort: Risk factors of ICU admission and ICU mortality

B Ahlström, R Frithiof, M Hultström… - Acta …, 2021 - Wiley Online Library
Background Several studies have recently addressed factors associated with severe
Coronavirus disease 2019 (COVID‐19); however, some medications and comorbidities …

Association of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and death in hypertensive patients with …

R Khera, C Clark, Y Lu, Y Guo, S Ren… - Journal of the …, 2021 - Am Heart Assoc
Background Despite its clinical significance, the risk of severe infection requiring
hospitalization among outpatients with severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] First results of the “lean European open survey on SARS-CoV-2-infected patients (LEOSS)”

CEM Jakob, S Borgmann, F Duygu, U Behrends… - Infection, 2021 - Springer
Purpose Knowledge regarding patients' clinical condition at severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) detection is sparse. Data in the international …

Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury

R Sarzani, F Giulietti, C Di Pentima… - … of Physiology-Lung …, 2020 - journals.physiology.org
A dysregulation of the renin-angiotensin system (RAS) has been involved in the genesis of
lung injury and acute respiratory distress syndrome from different causes, including several …

Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system …

FA Cadegiani, A Goren, CG Wambier - Medical hypotheses, 2020 - Elsevier
Abstract In coronavirus disease-19 (COVID-19), four major factors have been correlated with
worse prognosis: aging, hypertension, obesity, and exposure to androgen hormones …

Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study

D Collard, NS Nurmohamed, Y Kaiser, LF Reeskamp… - BMJ open, 2021 - bmjopen.bmj.com
Objectives Recent reports suggest a high prevalence of hypertension and diabetes in
COVID-19 patients, but the role of cardiovascular disease (CVD) risk factors in the clinical …